Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Food or edible as carrier for pharmaceutical
Reexamination Certificate
2000-09-28
2008-10-07
Hartley, Michael G. (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Food or edible as carrier for pharmaceutical
C514S054000
Reexamination Certificate
active
07431939
ABSTRACT:
The use of a dietary fiber or a mixture of dietary fibers for the manufacture of a composition, being a pharmaceutical composition or a functional food or a functional feed, for the prevention, the inhibition and/or the treatment of systemic infections in humans and in vertebrates caused by pathogenic bacteria is disclosed.A method for the prevention, the inhibition and/or the treatment of systemic infections in humans and in vertebrates caused by pathogenic bacteria, comprising administration to said beings, orally, through tube feeding or rectally, a composition containing an effective amount of a dietary fiber or mixture of dietary fibers is also disclosed.The dietary fiber is preferably a fructan, typically inulin and/or oligofructose, most preferably chicory inulin with an average degree of polymerization(DP)of at least 20.
REFERENCES:
patent: 5032579 (1991-07-01), Speights et al.
patent: 5051408 (1991-09-01), Cooper
patent: 5260279 (1993-11-01), Greenberg
patent: 5502180 (1996-03-01), Kunz et al.
patent: 5792754 (1998-08-01), Green et al.
patent: 5856313 (1999-01-01), Marco et al.
patent: 5972415 (1999-10-01), Brassart et al.
patent: 6001878 (1999-12-01), Van Leeuwen et al.
patent: 6241983 (2001-06-01), Paul et al.
patent: 6248375 (2001-06-01), Gilles et al.
patent: 6500805 (2002-12-01), Van Loo et al.
patent: 0 904 784 (1999-03-01), None
patent: 1 428 528 (2004-06-01), None
patent: 96/13271 (1996-05-01), None
patent: WO 02/26242 (2002-04-01), None
patent: WO 02/26242 (2002-04-01), None
E. J. Schiffrin et al., “Immune Modulation of Blood Leukocytes in Humans by Lactic Acid Bacteria: Criteria for Strain Selection1-3”, Am. J. Clin. Nutr., 66:515S-20S, 1997.
R. Berg et al., “Inhibition ofCandida albicansTranslocation from the Gastrointestinal Tract of Mice by Oral Administration ofSaccharomyces boulardii”, The Journal of Infectious Diseases, 168:1314-8, 1993.
Yano, et al., “Polysaccharide-Induced Protection of Carp Cyprinus-Carpio L. Against Bacterial Infection”, Journal of Fish Diseases, vol. 14, No. 5, 577-582, Database Accession No. PREV199293115402 XP002194171, Biosciences Information Service, Philadelphia, PA , Abstract (1991).
Roberfroid, et al., “The Bifidogenic Nature of Chicory Inulin and Its Hydrolysis Products”, Journal of Nutrition, 128, 1, 11-19, XP002194167 ISSN: 022-3166, Abstract (1998).
Gibson, “Dietary Modulation of the Human Gut Microflora Using the Prebiotics Oligofructose and Inulin”, Journal of Nutrition, 129, 7 Suppl., 1438S-1441S, XP002194168 ISSN: 0022-3166, Abstract (1999).
Gianotti, et al., “Fiber-Enriched Diet Prevents Bacterial Translocation from the Intestine to Systemic Organs”, Revista Italiana di Nutrizone Parenterale ed Enterale, 11, 1, 16-22, Abstract (1993).
Jenkins, et al., “Inulin, Oligofructose and Intestinal Function”, Journal of Nutrition, 129, 7 Suppl., 1431S-1433S XP002194169, ISSN: 0022-3166, Abstract (1999).
Menne, et al., “Fn-type Chicory Inulin Hydrolysate has a Prebiotic Effect in Humans”, Journal of Nutrition, 130, 5, 1197-1199, XP002194170, ISSN: 0022-3166, Abstract (2000).
Quan, et al., “DietaryBifidobacterium lactis(HN019) Enhances Resistance to OrgalSalmonella typhimuriumInfection in Mice”, Microbiology and Immunology, 213-222, 44, 4, Database Accession No. PREV200000229776 XP002194172, Abstract (2000).
Dazhong, et al., “Elemental Diet-Induced Bacterial Translocation Associated with Systemic and Intestinal Immune Suppression”, Journal of Parenteral and Enteral Nutrition, 22, 1, 37-41, Database Accession No. PREV199800097418, Abstract (1998).
Roberfroid, et al., “Dietary Fructans”, Annual Review of Nutrition, 18, 117-143, XP000856009, ISBN: 0-8243-2818-3, Abstract (1998).
Roberfroid, M., “Dietary Fiber, Inulin, and Oligofructose: a Review Comparing their Physiological Effects,” Critical Reviews in Food Science and Nutrition, vol. 33, No. 2, pp. 103-148, 1993.
Campbell, J.M., et al., “Selected Indigestible Oligosaccharides Affect Large Bowel Mass, Cecal and Fecal Short-Chain Fatty Acids, pH and Microflora in Rats,” American Society for Nutritional Sciences, pp. 130-136, 1997.
Mao, Y., et al., “Pectin-Supplemented Enteral Diet Reduces the Severity of Methotrexate-Induced Enterocolitis in Rats,” Pectin in Enterocolitis, vol. 31, No. 6, pp. 558-567, 1996.
Roberfroid, M.B., “Concepts in Functional Foods: The Case of inulin and Oligofructose,” American Society for Nutritional Sciences, pp. 1398S-1401S, 1999.
Ferguson, M.J., et al., “Production of short-chain fatty acids following in vitro fermentation of saccharides, saccharide esters, fructo-oligosaccharides, starches, modified starches, modified starches and non-starch polysaccharides,” Journal of the Sciences of Food and Agriculture, vol. 80, pp. 166-170, 2000.
Gibson, G.R., et al., “Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics,” The Journal of Nutrition, vol. 125, pp. 1401-1412, 1995.
Buddington Randal K.
Frippiat Anne
Van Loo Jan
DLA Piper (US) LLP
Hartley Michael G.
Mississippi State University
Silverman Eric E.
Tiense Suikerraffinaderij N.V.
LandOfFree
Inhibition of systemic infections in humans and vertebrates... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of systemic infections in humans and vertebrates..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of systemic infections in humans and vertebrates... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3998951